Latest ALS Stories
GULF SHORES, Ala., April 29, 2014 /PRNewswire/ -- If successful, Neuralgene's (http://www.neuralgene.com) PRCN-323 treatment
Forum Uniquely Brings Together Leading Family Offices and Their Foundations Seeking Impact Investment, Grant-Giving, and Philanthropy Opportunities within Health and Life Sciences New
Nationwide fundraising campaign to raise money for ALS research WASHINGTON, April 25, 2014 /PRNewswire-USNewswire/ -- Seventy-five years ago, on July 4, 1939, Lou Gehrig delivered
An ingredient found in Silly Putty could help scientists more efficiently turn human embryonic stem cells into fully functional specialized cells, according to research published online Sunday in the journal Nature Materials.
Will Also Present Update on Ongoing Phase II Trial ROCKVILLE, Md., April 7, 2014 /PRNewswire/ -- Neuralstem, Inc.
By studying nerve cells that originated in patients with a severe neurological disease, a University of Wisconsin-Madison researcher has pinpointed an error in protein formation that could be the root of amyotrophic lateral sclerosis.
EHE International Donates Window Display to Augie's Quest to Raise Awareness of ALS and Promote Participation in Funding Research for Treatments and a Cure CAMBRIDGE, Mass., April
WASHINGTON, March 31, 2014 /PRNewswire-USNewswire/ -- In work supported by The ALS Association, researchers have discovered a new ALS-causing gene and have linked its function to that of another
In the news release, Antioxidant Shows Promise in Supporting Treatment for Lou Gehrig's Disease, issued 24-Mar-2014 over PR Newswire, we are advised by the company
MONTEVIDEO, Uruguay, March 24, 2014 /PRNewswire/ -- Researchers at The Center of Free Radical and Biomedical Research at Facultad de Medicina, Universidad de la Republica in Uruguay
- A volcanic mudflow.